Current Protein Identity:C0LT38 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
4FQK Influenza B/Brisbane/60/2008 hemagglutinin Fab CR8059 complex Deposited 2012-06-25 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 16–362(347 aa) Fragment:UNP residues 16-362
Chain B 363–538(176 aa) Fragment:UNP residues 363-538
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 4.5;295 K;0.8 M sodium phosphate monobasic, 1.2 M potassium phosphate dibasic, 0.1 M sodium acetate, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K
Resolution 5.65 Å R-free 0.324
4FQK Influenza B/Brisbane/60/2008 hemagglutinin Fab CR8059 complex Deposited 2012-06-25 Assembly 2 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain C 16–362(347 aa) Fragment:UNP residues 16-362
Chain D 363–538(176 aa) Fragment:UNP residues 363-538
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 4.5;295 K;0.8 M sodium phosphate monobasic, 1.2 M potassium phosphate dibasic, 0.1 M sodium acetate, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K
Resolution 5.65 Å R-free 0.324
4FQM Structure of B/Brisbane/60/2008 Influenza Hemagglutinin Deposited 2012-06-25 Assembly 1 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain A 16–362(347 aa) Fragment:UNP residues 16-362
Chain B 363–538(176 aa) Fragment:UNP residues 363-538
Chain C 16–362(347 aa) Fragment:UNP residues 16-362
Chain D 363–538(176 aa) Fragment:UNP residues 363-538
Chain E 16–362(347 aa) Fragment:UNP residues 16-362
Chain F 363–538(176 aa) Fragment:UNP residues 363-538
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 10 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 9.5;295 K;20% PEG3350, 160 mM sodium fluoride, 20 mM Tris, pH 9.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K
Resolution 3.45 Å R-free 0.268
4FQM Structure of B/Brisbane/60/2008 Influenza Hemagglutinin Deposited 2012-06-25 Assembly 2 Other combination Homooligomer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain G 16–362(347 aa) Fragment:UNP residues 16-362
Chain H 363–538(176 aa) Fragment:UNP residues 363-538
Chain I 16–362(347 aa) Fragment:UNP residues 16-362
Chain J 363–538(176 aa) Fragment:UNP residues 363-538
Chain K 16–362(347 aa) Fragment:UNP residues 16-362
Chain L 363–538(176 aa) Fragment:UNP residues 363-538
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 9.5;295 K;20% PEG3350, 160 mM sodium fluoride, 20 mM Tris, pH 9.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K
Resolution 3.45 Å R-free 0.268
9X5W B/Brisbane/60/2008 HA in complex with BP-1A Deposited 2025-10-14 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 1–362(362 aa)
Chain B 363–550(188 aa)
Chain C 1–362(362 aa)
Chain D 363–550(188 aa)
Chain E 1–362(362 aa)
Chain F 363–550(188 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.76 Å
9X5X B/Brisbane/60/2008 HA in complex with FV2DP1-1B Deposited 2025-10-14 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 1–362(362 aa)
Chain B 363–550(188 aa)
Chain C 1–362(362 aa)
Chain D 363–550(188 aa)
Chain E 1–362(362 aa)
Chain F 363–550(188 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.76 Å
9X5Y B/Brisbane/60/2008 HA in complex with BO-6B Deposited 2025-10-14 Assembly 1 Other combination Heteromer;Protein × 12 PDB declaration: dodecameric(12) Consistent with protein count
Chain A 1–362(362 aa)
Chain B 363–550(188 aa)
Chain E 1–362(362 aa)
Chain F 363–550(188 aa)
Chain G 1–362(362 aa)
Chain I 363–550(188 aa)
Not recorded NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.5
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.65 Å